Galapagos NV (AMS: GLPG)
Netherlands
· Delayed Price · Currency is EUR
22.76
+0.04 (0.18%)
Jan 28, 2025, 5:39 PM CET
Galapagos NV Revenue
Galapagos NV had revenue of 59.85M EUR in the quarter ending September 30, 2024, a decrease of -50.14%. This brings the company's revenue in the last twelve months to 260.09M, down -52.19% year-over-year. In the year 2023, Galapagos NV had annual revenue of 239.72M, down -0.63%.
Revenue (ttm)
260.09M
Revenue Growth
-52.19%
P/S Ratio
5.61
Revenue / Employee
231.61K
Employees
1,123
Market Cap
1.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 239.72M | -1.53M | -0.63% |
Dec 31, 2022 | 241.25M | 6.87M | 2.93% |
Dec 31, 2021 | 234.38M | -243.67M | -50.97% |
Dec 31, 2020 | 478.05M | -356.85M | -42.74% |
Dec 31, 2019 | 834.90M | 517.06M | 162.68% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGalapagos NV News
- 7 days ago - Galapagos inks agreement with Catalent for experimental CAR-T therapy - Seeking Alpha
- 9 days ago - Galapagos To Spin Off Innovative Medicines Business - Forbes
- 22 days ago - Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus - Benzinga
- 22 days ago - Biotech Firm Galapagos to Split Into Two Entities, Cut Jobs - BNN Bloomberg
- 22 days ago - Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities - GlobeNewsWire
- 23 days ago - Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma - GlobeNewsWire
- 2 months ago - Galapagos NV (GLPG) Stock Surges Amid Strong Industry Performance - GuruFocus